Email Alert RSS
Volume 15 Issue 2
Mar.  2024
Turn off MathJax
Article Contents
Abstract
References
Related Articles
ZHU He, WEN Bei, XU Li, HUANG Yuguang. Mechanism of Wnt5a on Keratinocyte Regulating MMP9 for CRPS-Ⅰ Peripheral Sensitization[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(2): 335-343. DOI: 10.12290/xhyxzz.2023-0551
Citation: ZHU He, WEN Bei, XU Li, HUANG Yuguang. Mechanism of Wnt5a on Keratinocyte Regulating MMP9 for CRPS-Ⅰ Peripheral Sensitization[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(2): 335-343. DOI: 10.12290/xhyxzz.2023-0551
shu

Mechanism of Wnt5a on Keratinocyte Regulating MMP9 for CRPS-Ⅰ Peripheral Sensitization

  • Department of Anesthesiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China

Funds: 

National Natural Science Foundation of China 82271262

More Information
  • Corresponding author:

    XU Li, E-mail: pumchxuli@163.com

    HUANG Yuguang, E-mail: garypumch@163.com

  • Received Date: November 19, 2023
  • Accepted Date: December 06, 2023
  • Available Online: December 18, 2023
  • Issue Publish Date: March 29, 2024
    Graphical Abstract
    • Abstract
  •   Objective  To explore the mechanism of Wnt5a on keratinocyte involved in the peripheral sensitization of complex regional pain syndrome type-Ⅰ (CRPS-Ⅰ) by regulating the expression of MMP9, and search for potential therapeutic strategies.
      Methods  Cultured HaCaT cells were treated with oxygen glucose deprivation/re-oxygenation (OGD/R). The early stage of mitochondrial damage and membrane potential changes after OGD/R and the effects of Box5 (Wnt5a inhibitor) at different concentrations (20 μmol/L, 40 μmol/L) on MMP9 were explored. Adult male Sprague-Dawley rats were divided into Control group(n=8), CPIP group (n=8), Box5 (20) group (n=8) and Box5 (40) group (n=8). The rat chronic post-ischemia pain (CPIP) model was established to mimic the pathophysiological process of CRPS-Ⅰ. Box5 (20) group and Box5 (40) group were treated with intraplantar injection of 20 μmol/L and 40 μmol/L Box5 100 μL, respectively. The changes of mechanical withdrawal threshold and thermal withdrawal latency were measured within two weeks, and the skin inflammatory infiltration and keratosis were observed by HE staining. The expression of MMP9 was observed by immunofluorescence, and the levels of IL-1β and TNF-α in dorsal root ganglion of different groups were detected by ELISA.
      Results  Vitro experiment: After OGD/R treatment, the mitochondrial atrophy was observed in OGD/R group under transmission electron microscope and the average fluorescence intensity of MMP9 was found to increase significantly (P<0.001). Compared with Control group, the mitochondrial membrane potential in OGD/R group decreased significantly by JC-1 detection (P=0.027). Compared with OGD/R group, only Box5 (40) group had a statistically significant increase in mitochondrial membrane potential (P=0.046). Animal experiment: Behavioral tests showed that the mechanical pain threshold and thermal pain threshold of CPIP group were significantly decreased at each time point (D1, D2, D4, D10, D14) (all P<0.05). HE staining indicated that there was a large-scale infiltration of inflammatory cell in the dermis and excessive keratosis in the epidermis, and the thickness of stratum granulosum and stratum spinosum increased significantly (P < 0.001). Immunofluorescence analysis showed that the expression of MMP9 in CPIP group was significantly increased (P<0.001). Compared with CPIP group, the fluorescence intensity of MMP9 in Box5 (20) group (P=0.002) and Box5 (40) group (P<0.001) were significantly decreased. ELISA results showed that the concentrations of IL-1β (P=0.048) and TNF-α (P=0.002) in CPIP group were significantly increased. Compared with CPIP group, the concentrations of IL-1β (P=0.047) and TNF-α (P=0.047) were significantly decreased in Box5 (40) group.
      Conclusions  Peripheral ischemia reperfusion injury leads to overexpression of MMP9 on keratinocytes, resulting in CRPS-Ⅰ peripheral sensitization. Targeted inhibition of Wnt5a/MMP9 pathway can reverse pain behavior in rat model of CPIP, thus providing a strategy for clinical treatment of chronic pain.
    • FullText(HTML)
    • References (31)
  • [1]
    Shim H, Rose J, Halle S, et al. Complex regional pain syndrome: a narrative review for the practising clinician[J]. Br J Anaesth, 2019, 123(2): e424-e433. DOI: 10.1016/j.bja.2019.03.030
    [2]
    Louis M H, Meyer C, Legrain V, et al. Biological and psychological early prognostic factors in complex regional pain syndrome: a systematic review[J]. Eur J Pain, 2023, 27(3): 338-352. DOI: 10.1002/ejp.2068
    [3]
    Smart K M, Ferraro M C, Wand B M, et al. Physiotherapy for pain and disability in adults with complex regional pain syndrome (CRPS) types Ⅰ and Ⅱ[J]. Cochrane Database Syst Rev, 2022, 5(5): CD010853.
    [4]
    Sobeeh M G, Hassan K A, Silva A G, et al. Impact of different CRPS phenotypes and diagnostic criteria on quantita-tive sensory testing outcomes: systematic review and meta-analysis[J/OL]. Pain Med: pnad144. https://doi.org/10.1093/pm/pnad144.
    [5]
    Xie Y K, Luo H, Zhang S X, et al. GPR177 in A-fiber sensory neurons drives diabetic neuropathic pain via WNT-mediated TRPV1 activation[J]. Sci Transl Med, 2022, 14(639): eabh2557. DOI: 10.1126/scitranslmed.abh2557
    [6]
    Liu X, Bae C, Liu B L, et al. Development of opioid-induced hyperalgesia depends on reactive astrocytes controlled by Wnt5a signaling[J]. Mol Psychiatry, 2023, 28(2): 767-779. DOI: 10.1038/s41380-022-01815-0
    [7]
    Lu Y T, Zhang J T, Zeng F N, et al. Human PMSCs-derived small extracellular vesicles alleviate neuropathic pain through miR-26a-5p/Wnt5a in SNI mice model[J]. J Neuroinflammation, 2022, 19(1): 221. DOI: 10.1186/s12974-022-02578-9
    [8]
    Li J, Ruan S R, Jia J H, et al. Hydrogen attenuates postoperative pain through Trx1/ASK1/MMP9 signaling pathway[J]. J Neuroinflammation, 2023, 20(1): 22. DOI: 10.1186/s12974-022-02670-0
    [9]
    Deng W D, Ding Z B, Wang Y Y, et al. Dendrobine attenuates osteoclast differentiation through modulating ROS/NFATc1/MMP9 pathway and prevents inflammatory bone destruction[J]. Phytomedicine, 2022, 96: 153838. DOI: 10.1016/j.phymed.2021.153838
    [10]
    Genovese T, Cordaro M, Siracusa R, et al. Molecular and biochemical mechanism of cannabidiol in the management of the inflammatory and oxidative processes associated with endometriosis[J]. Int J Mol Sci, 2022, 23(10): 5427. DOI: 10.3390/ijms23105427
    [11]
    Martin L J, Smith S B, Khoutorsky A, et al. Epiregulin and EGFR interactions are involved in pain processing[J]. J Clin Invest, 2017, 127(9): 3353-3366. DOI: 10.1172/JCI87406
    [12]
    Zhu H, Wen B, Xu L, et al. Identification of potential Inflammation-Related genes and key pathways associated with complex regional pain syndrome[J]. Biomolecules, 2023, 13(5): 772. DOI: 10.3390/biom13050772
    [13]
    Rodriguez-Trillo A, Mosquera N, Pena C, et al. Non-canonical WNT5A signaling through RYK contributes to aggressive phenotype of the rheumatoid fibroblast-like synoviocytes[J]. Front Immunol, 2020, 11: 555245. DOI: 10.3389/fimmu.2020.555245
    [14]
    Jenei V, Sherwood V, Howlin J, et al. A t-butyloxy-carbonyl-modified Wnt5a-derived hexapeptide functions as a potent antagonist of Wnt5a-dependent melanoma cell invasion[J]. Proc Natl Acad Sci U S A, 2009, 106(46): 19473-19478. DOI: 10.1073/pnas.0909409106
    [15]
    Modi A D, Parekh A, Pancholi Y N. Evaluating pain behaviours: widely used mechanical and thermal methods in rodents[J]. Behav Brain Res, 2023, 446: 114417. DOI: 10.1016/j.bbr.2023.114417
    [16]
    Zhu A, Shen L, Xu L, et al. Wnt5a mediates chronic post-thoracotomy pain by regulating non-canonical pathways, nerve regeneration, and inflammation in rats[J]. Cell Signal, 2018, 44: 51-61. DOI: 10.1016/j.cellsig.2018.01.017
    [17]
    Simonetti M, Kuner R. Spinal Wnt5a plays a key role in spinal dendritic spine remodeling in neuropathic and inflammatory pain models and in the proalgesic effects of peripheral Wnt3a[J]. J Neurosci, 2020, 40(35): 6664-6677. DOI: 10.1523/JNEUROSCI.2942-19.2020
    [18]
    Ji R R, Xu Z Z, Wang X Y, et al. Matrix metalloprotease regulation of neuropathic pain[J]. Trends Pharmacol Sci, 2009, 30(7): 336-340. DOI: 10.1016/j.tips.2009.04.002
    [19]
    Pan C L, Wang C Y, Zhang L, et al. Procyanidins attenuate neuropathic pain by suppressing matrix metalloproteinase-9/2[J]. J Neuroinflammation, 2018, 15(1): 187. DOI: 10.1186/s12974-018-1182-9
    [20]
    Shan Y L, Tan S, Lin Y Y, et al. The glucagon-like peptide-1 receptor agonist reduces inflammation and blood-brain barrier breakdown in an astrocyte-dependent manner in experimental stroke[J]. J Neuroinflammation, 2019, 16(1): 242. DOI: 10.1186/s12974-019-1638-6
    [21]
    Harrington J S, Ryter S W, Plataki M, et al. Mitochondria in health, disease, and aging[J]. Physiol Rev, 2023, 103(4): 2349-2422. DOI: 10.1152/physrev.00058.2021
    [22]
    Zeng X, Zhang Y D, Ma R Y, et al. Activated Drp1 regulates p62-mediated autophagic flux and aggravates inflammation in cerebral ischemia-reperfusion via the ROS-RIP1/RIP3-exosome axis[J]. Mil Med Res, 2022, 9(1): 25.
    [23]
    Smart K M, Wand B M, O'Connell N E. Physiotherapy for pain and disability in adults with complex regional pain syndrome (CRPS) types Ⅰ and Ⅱ[J]. Cochrane Database Syst Rev, 2016, 2(2): CD010853.
    [24]
    Lloyd E C O, Dempsey B, Romero L. Complex regional pain syndrome[J]. Am Fam Physician, 2021, 104(1): 49-55.
    [25]
    Wang J, Yin C Y, Pan Y S, et al. CXCL13 contributes to chronic pain of a mouse model of CRPS-Ⅰ via CXCR5-mediated NF-κB activation and pro-inflammatory cytokine production in spinal cord dorsal horn[J]. J Neuroinflamma-tion, 2023, 20(1): 109. DOI: 10.1186/s12974-023-02778-x
    [26]
    Palandi J, Mack J M, De Araújo I L, et al. Animal models of complex regional pain syndrome: a scoping review[J]. Neurosci Biobehav Rev, 2023, 152: 105324. DOI: 10.1016/j.neubiorev.2023.105324
    [27]
    Huntley G W. Synaptic circuit remodelling by matrix metalloproteinases in health and disease[J]. Nat Rev Neurosci, 2012, 13(11): 743-757. DOI: 10.1038/nrn3320
    [28]
    Page-McCaw A, Ewald A J, Werb Z. Matrix metalloproteinases and the regulation of tissue remodelling[J]. Nat Rev Mol Cell Biol, 2007, 8(3): 221-233.
    [29]
    Wells J M, Gaggar A, Blalock J E. MMP generated matrikines[J]. Matrix Biol, 2015, 44/46: 122-129. DOI: 10.1016/j.matbio.2015.01.016
    [30]
    MacLauchlan S, Zuriaga M A, Fuster J J, et al. Genetic deficiency of Wnt5a diminishes disease severity in a murine model of rheumatoid arthritis[J]. Arthritis Res Ther, 2017, 19(1): 166. DOI: 10.1186/s13075-017-1375-0
    [31]
    Jang J, Jung Y, Kim Y, et al. LPS-induced inflammatory response is suppressed by Wnt inhibitors, Dickkopf-1 and LGK974[J]. Sci Rep, 2017, 7(1): 41612. DOI: 10.1038/srep41612
    • Related Articles

  • Related Articles

    [1]ZHOU Yongtai, YANG Zhenyu, LI Yan, WU Jiajing, ZHAO Bo. Research Progress on the Mechanism of Lipocalin-2 in Neurological Diseases[J]. Medical Journal of Peking Union Medical College Hospital, 2025, 16(2): 330-337. DOI: 10.12290/xhyxzz.2025-0028
    [2]XU Kexin, LI Guozhuang, WU Zhihong, ZHANG Jianguo, DISCO(Deciphering Disorders Involving Scoliosis & Comorbidities) Study Group, WU Nan. Progress in Clinical Diagnosis and Management of Short Stature in Ehlers-Danlos Syndromes[J]. Medical Journal of Peking Union Medical College Hospital, 2025, 16(1): 163-170. DOI: 10.12290/xhyxzz.2024-0173
    [3]ZHANG Shan, LIU Jie. Interpretation of NCCN Clinical Practice Guidelines for Primary Cutaneous Lymphomas (Version 1.2024) Based on the Current Diagnosis and Treatment Status of China[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(5): 1029-1037. DOI: 10.12290/xhyxzz.2024-0605
    [4]KE Dandan, JIA Nan, CUI Puan, HE Zhong. Current Situation, Challenges and Suggestions for the Development of Primary Health Care Services in China in the Post Pandemic Era[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(1): 45-51. DOI: 10.12290/xhyxzz.2023-0290
    [5]GAO Yicheng, LIU Zhihan, TAO Liyuan, CAO Rui, XIA Ruyu, FENG Yuting, FANG Rui, DENG Yingjie, XIANG Wenyuan, FEI Yutong. Considerations and Methodological Suggestions on Health Equity in Clinical Practice Guideline Development[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(6): 1319-1324. DOI: 10.12290/xhyxzz.2023-0096
    [6]SUN Wenjuan, ZHANG Bo. Current Situation and Implications of Novel Antitumer Drugs in China[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(6): 1036-1044. DOI: 10.12290/xhyxzz.2021-0521
    [7]ZHANG Shan, LIU Zhaorui, LIU Jie. Relationship Between SerpinB9 and Tumors and Research Progress of SerpinB9 in Skin Tumors[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(5): 852-857. DOI: 10.12290/xhyxzz.2021-0805
    [8]ZHANG Xiao, CHEN Youxin. Current Situation and Prospect of Teleophthalmology[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(5): 755-760. DOI: 10.12290/xhyxzz.2021-0198
    [9]NING Yating, YANG Qiwen, CHEN Xinfei, YU Jinhan, LI Xue, XU Yingchun. Current Situation and Prospect of New Techniques for Rapid Clinical Microbiological Testing[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(4): 427-432. DOI: 10.12290/xhyxzz.2021-0387
    [10]Chen-xi YU, Shui SUN. Roles of Long Noncoding RNAs in the Development and Progression of Osteoarthritis[J]. Medical Journal of Peking Union Medical College Hospital, 2020, 11(1): 85-90. DOI: 10.3969/j.issn.1674-9081.20170138

  • Cited by

    Periodical cited type(4)

    1. 窦紫岩，钱文红，孔邻润，陈晔，李明亮，张静波. 非酒精性脂肪性肝病检出率现状及其影响因素：基于北京市32万人群数据. 中国全科医学. 2024(02): 144-149+155 .
    2. 王伟，缪海江，王新宇. 木香流气饮联合多烯磷脂酰胆碱胶囊对非酒精性脂肪肝肝郁脾虚证患者的效果观察. 深圳中西医结合杂志. 2024(06): 46-49 .
    3. 韩炜，宋叶君，张改萍，田晓英，付素芳，赵芳，王俊，周冉，张思宇，杜金星. 非酒精性脂肪肝病人健康减重的证据总结. 全科护理. 2024(23): 4450-4453 .
    4. 吴风，孔丽蕊，谭志群. 2型糖尿病合并NAFLD患者铁蛋白、TyG-BMI变化及与脂肪变性程度的相关性. 新疆医科大学学报. 2023(10): 1338-1343 .

    Other cited types(2)

Catalog

    Get Citation
    PDF
    XML

    Article Metrics

    Article views PDF downloads Cited by(6)
    Related
    Address：Room 302,Third Floor,Building 7, No. 1 Shuaifuyuan, Wangfujing, Dongcheng District, Beijing 100730, China
    Tel：010-69154261/4262
    E - mail：medj@pumch.cn mjpumch@126.com
    Copyright of website：Editorial Office of Medical Journal of Peking Union Medical College Hospital

      Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

      /

      DownLoad:  Full-Size Img  PowerPoint
      Return
      Return
      x Close Forever Close